Widecka K, Marzecka J, Goździk J, Gruszczyńska M, Ciechanowski K, Czekalski S
Kliniki Endokrynologii i Chorób Przemiany Materii PAM, Szczecinie.
Pol Tyg Lek. 1994;49(10-11):228-30.
The aim of the study was the comparison of the effect of seven day treatment with nifedipine (2 x 10 mg daily) and subsequently with verapamil (3 x 40 mg daily) on blood pressure, heart rate, plasma ANP, cGMP, renin activity (PRA), aldosterone (ALDO) concentrations in patients with primary hypertension. The material consisted of 12 untreated patients with primary arterial hypertension Io WHO. These results suggest that short-term treatment with nifedipine and subsequently with verapamil in patients with primary hypertension Io WHO not influence on plasma ANP, cGMP, PRA and ALDO in spite of blood pressure reduction and the changes in heart rate. It seems that ANP did not participate in hypotensive action of nifedipine and verapamil. No augmentation of urinary sodium excretion was found after short-term treatment with nifedipine or verapamil.
本研究的目的是比较硝苯地平(每日2次,每次10毫克)治疗7天,随后维拉帕米(每日3次,每次40毫克)治疗对原发性高血压患者血压、心率、血浆心钠素(ANP)、环磷酸鸟苷(cGMP)、肾素活性(PRA)、醛固酮(ALDO)浓度的影响。研究材料包括12例未经治疗的世界卫生组织(WHO)原发性动脉高血压患者。这些结果表明,对于WHO原发性高血压患者,短期使用硝苯地平并随后使用维拉帕米治疗,尽管血压降低且心率有变化,但对血浆ANP、cGMP、PRA和ALDO没有影响。似乎心钠素不参与硝苯地平和维拉帕米的降压作用。短期使用硝苯地平或维拉帕米治疗后,未发现尿钠排泄增加。